Zhongyi Yang

State Key Laboratory Of Medicinal Chemical Biology
Changhongjie, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Nerandomilast attenuates idiopathic inflammatory myopathy-associated interstitial lung disease via inhibiting proliferation and differentiation of B cells.

Nerandomilast attenuates idiopathic inflammatory myopathy-associated interstitial lung disease via inhibiting proliferation and differentiation of B cells.

Journal: Frontiers in immunology

Published: December 18, 2025

Correction: Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Correction: Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 23, 2025

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Journal: Scientific reports

Published: July 28, 2025

Zanubrutinib mitigates pulmonary fibrosis in aged mice by targeting the Wnt/β-catenin signaling pathway.

Zanubrutinib mitigates pulmonary fibrosis in aged mice by targeting the Wnt/β-catenin signaling pathway.

Journal: Biochemical pharmacology

Published: July 08, 2025

Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway.

Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway.

Journal: Biomolecules

Published: June 16, 2025

Corrigendum to "Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation" [Int. Immunopharmacol. 140 (2024) 112894].

Corrigendum to "Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation" [Int. Immunopharmacol. 140 (2024) 112894].

Journal: International immunopharmacology

Published: June 03, 2025

Correction: Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice.

Correction: Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice.

Journal: BMC pulmonary medicine

Published: April 11, 2025

BI 1015550 Improves Silica-Induced Silicosis and LPS-Induced Acute Lung Injury in Mice.

BI 1015550 Improves Silica-Induced Silicosis and LPS-Induced Acute Lung Injury in Mice.

Journal: Molecules (Basel, Switzerland)

Published: February 04, 2025

Lenalidomide attenuates cardiac fibrosis and inflammation induced by β-adrenergic receptor activation.

Lenalidomide attenuates cardiac fibrosis and inflammation induced by β-adrenergic receptor activation.

Journal: International immunopharmacology

Published: January 23, 2025

Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway.

Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway.

Journal: International immunopharmacology

Published: October 20, 2024

Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Journal: Scientific reports

Published: September 29, 2024

Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 12, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026